UPDATE 1-AMO blasts shareholder's opposition to Bausch deal

(Reuters) - CHICAGO, July 11 - Eye care products maker
Advanced Medical Optics Inc on Wednesday fired back at
its third largest shareholder, ValueAct Capital, which opposes
the company's takeover bid for Bausch & Lomb Inc .




Advanced Medical Optics Chief Executive James Mazzo,
responding to a critical letter from ValueAct, said he was
"surprised and disappointed" by ValueAct's opposition to the
$4.23 billion hostile bid for Bausch & Lomb.


Read more at Reuters.com Bonds News